...
Why us? Why us? please click dropdown
4.8/5 out of 3,500+ reviews
Regulated: CQC Registered | 1-5796078466
  • Verified Content: Approved by the Women’s Health Clinic Clinical Team.
  • Educational Use: This is not a substitute for professional medical advice, diagnosis, or treatment.
  • Clinical Assessment: Individual suitability is determined by a clinician; results may vary.
  • Non-NHS: Private healthcare provider only. Pricing varies by treatment and site. Availability varies by clinical location.
  • MEDICAL EMERGENCY:

    If you need urgent help, use NHS 111. For a life-threatening emergency, call 999.

Author Find more about the author
Dr Farzana Khan

Dr Farzana Khan

Verified

Dr Farzana Khan qualified as an MD from the University of Copenhagen in 2003. She has worked in dermatology and obstetrics & gynaecology across the North of England and completed her MRCGP (CCT, 2013) and the Diploma of the Faculty of Sexual & Reproductive Health (2013). Her clinical focus is vaginal health—including dryness/GSM, sexual function concerns, lichen sclerosus, and comfort or volume changes. She offers careful assessment, discusses medical and conservative options first, and considers selected regenerative or aesthetic treatments where appropriate. Dr Farzana also trains clinicians as a KOL/Trainer with Neauvia, Asclepion Laser, and RegenLab (since 2023). Ongoing CPD includes IMCAS, CCR, ACE and expert training in women’s intimate fillers, PRP, and polynucleotide injectables. Her approach is simple: clear explanations, realistic expectations, and shared decision-making.

MD MRCGP DFFP
Was this answer helpful?
Authored and medically reviewed by Dr Farzana Khan on 11 July 2026
Rate Dr Farzana's explanation
Differentiating lichen sclerosus from vulvar aphthous ulcers or Behcet's di... | WHC Clinical FAQ

Differentiating lichen sclerosus from vulvar aphthous ulcers or Behcet's di... | WHC Clinical FAQ

Differentiating lichen sclerosus from vulvar aphthous ulcers or Behcet's di... | WHC Clinical FAQ

Differentiating lichen sclerosus from vulvar aphthous ulcers or Behcet's di... | WHC Clinical FAQ

Does lichen sclerosus indicate immune system problems? | WHC Clinical FAQ

Does lichen sclerosus indicate immune system problems? | WHC Clinical FAQ

Lichen sclerosus and loss of vaginal elasticity | WHC Clinical FAQ

Lichen sclerosus and loss of vaginal elasticity | WHC Clinical FAQ




Ulcer review


Biopsy threshold


Red flags

Women’s Health Clinic FAQ

Differentiating lichen sclerosus from vulval aphthous ulcers or Behcet's disease.

A non-healing vulval ulcer in lichen sclerosus should be taken seriously without making every sore area sound like cancer.

Direct answer

Vulval aphthous ulcers and Behcet's disease usually behave differently from lichen sclerosus, so recurrent painful ulcers, oral ulcers or systemic symptoms need a broader differential diagnosis.

The safest answer keeps examination, infection review, inflammatory mimics and biopsy thresholds clear.


Educational only. Suitability and next steps should be confirmed after consultation. Results vary. Not a cure.

Women's Health Clinic consultation about differentiating lichen sclerosus from vulval aphthous ulcers or behcet's disease.

Ulcer assessment

At a glance

These are the main points to understand before deciding whether symptoms need self-care, prescribed treatment, specialist review or urgent advice.

At a glance

Clinical summary

Main area

Vulval ulcer

Care pattern

Review-led

Watch for

Non-healing ulcer

Next step

Prompt assessment

Important safety note

New, changing or painful skin symptoms should be assessed rather than repeatedly self-treated, especially if there is bleeding, ulceration, urinary change or rapid scarring.

Diagnosis
Symptoms
Treatment
Review
Safety




Detailed answer

The clinical answer

The useful answer starts by separating active inflammation, established scarring, irritant symptoms, infection, GSM overlap, urinary involvement and non-standard treatment claims.

Direct answer

The reader needs to know when ulceration is part of fragile skin and when it requires broader assessment, biopsy or urgent review.

Activity
Scarring
Treatment
Follow-up

Direct answer

Start with the exact concern and the anatomy involved, because vulval skin, vaginal tissue, the introitus, foreskin, meatus and urethra need different thinking.

Ulcer pattern and duration

Symptoms should be interpreted alongside appearance, fissures, pain, urinary features, treatment history and whether the problem is new or changing.

Cancer and infection red flags

Treatment choices should keep prescribed anti-inflammatory care central and frame adjunctive or supportive options realistically.

Differential diagnosis

Follow-up matters when symptoms persist, recur, affect sex or urination, or change vulval or penile architecture.

How the research shapes the answer

Diagnostic Overlap: Misdiagnosis is common; conditions are frequently misattributed to recurrent candidiasis or herpes simplex virus (HSV). Role of Biopsy: Biopsy is not routinely required for clear-cut VAU or typical LS, but it is.

The research synthesis shaped the structure, while final wording avoids complete treatment framing, sexual-wellness marketing, treatment ranking, device hype and promises of tissue reversal.





Patient safety

Why this distinction matters

This distinction matters because lichen sclerosus can be missed, over-simplified or overtreated when symptoms are reduced to itching, dryness, cosmetic concern or sexual discomfort alone.

It avoids false reassurance

A persistent ulcer should not be labelled as a simple flare without assessment.

It keeps urgency proportionate

Clear biopsy thresholds reduce both panic and delay.

It broadens the differential

Infection, trauma, aphthous ulceration and Behcet's disease may need different pathways.

It protects surveillance

Long-standing LS needs careful monitoring for changing lesions.

Calm, precise care

Good lichen sclerosus information should reduce shame and confusion while making review thresholds clearer.

The right next step may be reassurance, swabs, biopsy, steroid review, GSM care, urology, paediatric review, specialist vulval care or urgent advice.





Considerations

What to consider

LS: Prescribe 30g of 0.05% clobetasol propionate ointment for a 3-month period. Advise against the use of soaps; recommend emollient soap substitutes. VAU: Focus heavily on pain control. Recommend 2% lidocaine jelly prior to.

Consultation priorities

Track symptoms, visible change, fissures, pain, urine stinging, urinary stream, treatment use, irritants, sexual discomfort, scarring and whether symptoms are improving.

History
Examination
Treatment
Follow-up

Check duration

Non-healing or recurrent ulceration needs review.

Look for associated symptoms

Bleeding, lump, severe pain, oral ulcers or systemic symptoms matter.

Consider tests

Swabs, biopsy or specialist referral may be appropriate.

Avoid repeat self-treatment

Persistent ulceration should not be managed with repeated creams alone.

What not to assume

Do not assume every flare is thrush, every white patch is lichen sclerosus, or every symptom can be solved with a procedure.

LS: A lifelong, incurable condition. Induction therapy usually lasts 3 months, followed by long-term maintenance (e.g., twice-weekly steroid application) to prevent structural distortion and disease flares. VAU: Generally self-limiting, with ulcers typically resolving fully.





Common concerns and myths

Common misconceptions

These corrections keep the page practical, cautious and less vulnerable to online overclaims.

Myth: A vulval ulcer in lichen sclerosus is always just a fissure

Reality: symptoms, examination and treatment response matter more than assumptions.

Myth: Biopsy is never needed if LS is already diagnosed

Reality: symptoms, examination and treatment response matter more than assumptions.

Myth: Behcet's disease and lichen sclerosus ulcers behave the same way

Reality: symptoms, examination and treatment response matter more than assumptions.

Diagnosis comes first

Similar symptoms can come from lichen sclerosus, thrush, GSM, vitiligo, lichen planus, irritant dermatitis, urinary infection or pelvic-floor guarding.

Treatment should stay proportionate

Supportive care, prescribed treatment, hormones, surgery, dilators and adjunctive options have different roles and should not be blurred together.





Safety checklist

Safety checklist

Use these checks to decide whether symptoms are more suitable for routine review, specialist review or urgent advice.

Is the diagnosis clear?

Persistent or recurrent symptoms should not be repeatedly treated without examination.

Is disease active?

Itch, fissures, soreness, texture change or new whitening may suggest active inflammation.

Is function affected?

Pain with sex, urine stinging, narrowing, stream change or daily discomfort should be discussed.

Are red flags present?

Bleeding, non-healing ulcers, new lumps, rapid change or urinary retention need prompt advice.

More reassuring signs

The situation is more reassuring when symptoms are improving, diagnosis is clear, treatment technique is understood and follow-up is planned.

Improving
Known plan
Review booked

Reasons to seek advice

Seek advice for severe pain, unexplained bleeding, non-healing ulcers, new lumps, urinary stream change, retention, fever, spreading redness or safeguarding concerns.

Bleeding
Ulcer
Urinary change




When to escalate

When to seek medical help

Some symptoms should not be managed with self-care, online advice or repeat treatment alone.

Use NHS 111 online

Changing skin

A new lump, non-healing ulcer, bleeding, rapid scarring or marked colour or texture change should be assessed.

Pain or urinary change

Severe pain, urine retention, stream change, spraying or persistent urine stinging should be reviewed.

Infection or safeguarding concerns

Fever, spreading redness, discharge, child safeguarding concerns or unexplained injury patterns need appropriate advice.

Emergency symptoms

Call 999 for life-threatening symptoms such as collapse, chest pain, breathing difficulty or severe allergic reaction.

Use NHS 111 for urgent advice or call 999 in a life-threatening emergency. This page is educational and does not replace individual medical assessment.

Additional clinical context

How to use this answer

Use this page to separate active lichen sclerosus, established scarring, irritant symptoms, urinary involvement, GSM overlap and treatment marketing. The safest next step depends on symptoms, examination and whether the concern is changing.

What to bring to review

Helpful details include symptom timing, itch, soreness, fissures, urine stinging, urinary stream, visible change, sexual discomfort, treatment use, irritants, previous swabs or biopsy, and whether symptoms are improving or worsening.

Next step

Book a confidential consultation

A consultation can assess ulcer duration, pain, appearance, treatment response, infection signs and whether biopsy or specialist review is appropriate.

View Research Sources (12 Sources)
• NHS - Lichen sclerosus NHS - Vulval cancer British Association of Dermatologists - Lichen sclerosus in females British Journal of Dermatology - BAD guideline PubMed - lichen sclerosus non-healing vulval ulcer biopsy PubMed - vulval aphthous ulcer Behcet lichen sclerosus differential British Association of Dermatologists - Lichen sclerosus in males BSSVD - Management of lichen sclerosus RCOG - Skin conditions of the vulva NHS - Vaginal dryness British Menopause Society - GSM consensus statement ACOG - Elective female genital cosmetic surgery
• NHS - Lichen sclerosus
• NHS - Vulval cancer
• NHS - Vaginal dryness
• RCOG - Skin conditions of the vulva
• British Menopause Society - GSM consensus statement
• PubMed - lichen sclerosus non-healing vulval ulcer biopsy
• PubMed - vulval aphthous ulcer Behcet lichen sclerosus differential
• British Journal of Dermatology - BAD guideline
• British Association of Dermatologists - Lichen sclerosus in females
• British Association of Dermatologists - Lichen sclerosus in males
• BSSVD - Management of lichen sclerosus

These 12 source names are selected from 12 display-ready sources, with a raw audit trail of 54 imported records. Additional reviewed material included UK clinical guidance, peer-reviewed clinical papers; duplicate, low-relevance and non-clinical records were removed before display.

Educational only. This information is for education only and is not a substitute for professional medical advice, diagnosis or treatment. Results vary. Not a cure.

  • Clinical Assessment: Individual suitability is determined by a clinician; results may vary.
  • Non-NHS: Private healthcare provider only. Pricing varies by treatment and site. Availability varies by clinical location.